NCT02700217

Brief Summary

About 1100 living donor nephrectomies are performed in the UK every year contributing to almost 35% of all the kidney transplants. Laparoscopic surgical techniques are general employed for donor nephrectomy as they are associated with a shorter hospital stay and faster return to normal physical functioning. Local anaesthetic infiltration technique with or without spinal anaesthesia in combination with a general anaesthetic is increasingly being used as part of enhanced recovery programme across general surgery. The impact of combined spinal and general anaesthesia along with local infiltration and rectus sheath blocks on acute pain has not been studied in patients undergoing hand assisted laparoscopic live donor nephrectomy. The investigators plan to investigate whether adding a spinal anaesthetic to a conventional general anaesthetic technique actually influences clinical outcomes of length of hospital stay and acute pain in patients undergoing hand assisted laparoscopic live donor nephrectomy. The investigators plan to randomise 90 patients undergoing hand assisted laparoscopic live donor nephrectomy over 24 month period at Central Manchester University hospitals and divide them in two groups of 45 each. Group A will receive a general anaesthetic (GA) with spinal anaesthesia (Spinal group) and Group B will receive a GA with a rectus sheath block (Rectus sheath group) and local anaesthetic infiltration

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable surgery

Timeline
Completed

Started Mar 2016

Typical duration for not_applicable surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2016

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 7, 2016

Completed
9 days until next milestone

Study Start

First participant enrolled

March 16, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2019

Completed
Last Updated

March 17, 2020

Status Verified

March 1, 2020

Enrollment Period

3 years

First QC Date

February 9, 2016

Last Update Submit

March 16, 2020

Conditions

Keywords

Donor Nephrectomy

Outcome Measures

Primary Outcomes (1)

  • Assessment of readiness for discharge from hospital to determine Length of stay, after renal surgery, using a blinded Nurse assessment of patient.

    From Day 2 a nurse blinded to both groups will assess the readiness for discharge at 10:00, 14:00 and at 18:00 hours. The patient would be considered suitable for discharge if the following criteria are met: (i) Able to get in and out of bed, (ii) Able to get dressed, (iii) Able to go to toilet without walking aids, (iv) Pain manageable with oral analgesics, (v) Patient willing to be discharged. Length of stay (LOS) would be calculated as the time from the end of surgery until the subject met the discharge criteria from the ward. The actual day and time the patient leaves the hospital would be noted as well.

    5 days

Secondary Outcomes (5)

  • Assessment of Pain from surgery to discharge tested at intervals using an 11 point linear numerical rating scale utilised for assessment of pain.

    5 days

  • The total patient controlled analgesia (PCA) morphine consumption

    5 days

  • Assessing the side effects of the anaesthetic technique specifically looking at PDPH throughout the recovery process in hospital, using the PONV

    5 days

  • Assessing the side effects of the anaesthetic technique specifically looking at PDPH throughout the recovery process in hospital, using the VAS

    5 days

  • Assessment of Patient Satisfaction using the Patient Anaesthesia Satisfaction Scale (PASS)

    5 days

Study Arms (2)

Spinal Anaesthesia

EXPERIMENTAL

2.5ml of heavy 0.5% Bupivacaine, 400mg of Diamorphine (Spinal Anaesthesia) \& IV infusion of Remifentanil 0.2-0.3ug/kg/min, Propofol 2-3mg/kg and 0.2 mg/kg of Cistracurium (General Anaesthesia)

Procedure: Bupivacaine and DiamorphineProcedure: Remifentanil, Propofol and Cistracurium

Rectus Sheath Injection

ACTIVE COMPARATOR

50ml of 0.25% I-Bupivacaine max 2mg/kg (IV block Anaesthesia) injected into rectus sheath bilaterally \& IV infusion of Remifentanil 0.2-0.3ug/kg/min, Propofol 2-3mg/kg and 0.2 mg/kg of Cistracurium (General Anaesthesia)

Procedure: Remifentanil, Propofol and CistracuriumProcedure: Bupivacaine and Rectus Sheath injection

Interventions

Spinal Anaesthesia
Rectus Sheath InjectionSpinal Anaesthesia
Rectus Sheath Injection

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1-2 status
  • Patients aged between 18-65 years

You may not qualify if:

  • Patient refusal
  • Pregnancy
  • Allergy to bupivacaine
  • Patients who have had previous abdominal surgery
  • Patients having chronic pain or any medications for chronic pain
  • Any patient in whom spinal anaesthesia is contra-indicated
  • Patients on anti-platelet or anti-thrombotic therapy.
  • Patient requiring interpreter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Manchester University Hospitals NHS Foundation Trust

Manchester, M13 9WL, United Kingdom

Location

Related Publications (1)

  • Bhatia K, Columb M, Wadsworth R, Macnab W, Jepegnanam C, Campbell T, Van Dellen D. Effect of rectus sheath block vs. spinal anaesthesia on time-to-readiness for hospital discharge after trans-peritoneal hand-assisted laparoscopic live donor nephrectomy: A randomised trial. Eur J Anaesthesiol. 2021 Apr 1;38(4):374-382. doi: 10.1097/EJA.0000000000001337.

MeSH Terms

Interventions

BupivacaineHeroinRemifentanilPropofol

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2016

First Posted

March 7, 2016

Study Start

March 16, 2016

Primary Completion

March 5, 2019

Study Completion

March 5, 2019

Last Updated

March 17, 2020

Record last verified: 2020-03

Locations